Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom


Journal article


Vanessa W S Ng, Kenneth K C Man, Le Gao, E. Chan, E. Lee, J. Hayes, I. Wong
Pharmacoepidemiology and drug safety, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Ng, V. W. S., Man, K. K. C., Gao, L., Chan, E., Lee, E., Hayes, J., & Wong, I. (2021). Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom. Pharmacoepidemiology and Drug Safety.


Chicago/Turabian   Click to copy
Ng, Vanessa W S, Kenneth K C Man, Le Gao, E. Chan, E. Lee, J. Hayes, and I. Wong. “Bipolar Disorder Prevalence and Psychotropic Medication Utilisation in Hong Kong and the United Kingdom.” Pharmacoepidemiology and drug safety (2021).


MLA   Click to copy
Ng, Vanessa W. S., et al. “Bipolar Disorder Prevalence and Psychotropic Medication Utilisation in Hong Kong and the United Kingdom.” Pharmacoepidemiology and Drug Safety, 2021.


BibTeX   Click to copy

@article{vanessa2021a,
  title = {Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom},
  year = {2021},
  journal = {Pharmacoepidemiology and drug safety},
  author = {Ng, Vanessa W S and Man, Kenneth K C and Gao, Le and Chan, E. and Lee, E. and Hayes, J. and Wong, I.}
}

Abstract

Bipolar disorder (BPD) is often an under‐addressed mental disorder. Limited studies have investigated its epidemiology and drug utilisation in Hong Kong (HK) and the United Kingdom (UK) and thus local prescribing practices remain unclear. This study aimed to determine the prevalence of BPD and the prescribing of psychotropic medications as maintenance treatment from 2001–2018 in HK and the UK.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in